Unicycive Therapeutics, Inc. (UNCY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 91.67M |
| Enterprise Value | 62.67M |
| P/E Ratio | -3.36 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.84 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.09 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.49 |
| Return On Equity | -0.89 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -572,000 |
| EBITDA | -25.91M |
| Net Income | -26.56M |
| Diluted EPS | -1.67 |
Balance Sheet
| Total Cash | 61.43M |
| Total Cash/Share | 2.28 |
| Total Debt | 671,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 3.81 |
| Book Value Per Share | 1.98 |
Price History
| 52-Week Change | 34.05 |
| 52-Week High | 8.74 |
| 52-Week Low | 3.71 |
| Moving Average 50 Days | 5.81 |
| Moving Average 200 Days | 6.4 |
Statistics
| Average Volume | 1.55M |
| Shares Outstanding | 26.7M |
| % Held by Institutions | 4.14 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 20, 2025 |
AD
